Cempra Inc is a clinical-stage pharmaceutical company which is developing antibiotics to meet critical unmet medical needs in the treatment of bacterial infectious diseases particularly respiratory tract infections and skin and skin structure infections.


Updates from The Motley Fool

Latest updates on Cempra from Fool.com.


Stock Performance

CEMP vs. S&P 500 | 2 Year Performance
View Interactive CEMP Charts
Sponsored by

Key Data Points

Primary metrics and data points about Cempra.
Current Price: $24.72
Prev Close: $25.21
Open: $24.91
Bid: $23.75
Ask: $25.84
Day's Range: $24.55 - $25.25
52wk Range: $14.03 - $36.49
Volume: 593,457
Avg Vol 782,356
Market Cap: $1.09B
P/E (ttm): -11.30
EPS (ttm): -$2.23
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Cempra.
CAPS Rating 4 out of 5
 
73 Outperform
5 Underperform
CAPS All Stars
 
18 Outperform
0 Underperform

How do you think Cempra will perform against the market?



You pick for Cempra is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Cempra.

Cempra Inc is a clinical-stage pharmaceutical company which is developing antibiotics to meet critical unmet medical needs in the treatment of bacterial infectious diseases particularly respiratory tract infections and skin and skin structure infections.

  • Exchange: NASDAQ